Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma
Anusara Daenthanasanmak, Richard N. Bamford, Makoto Yoshioka, et al.
Blood Advances (2022) Vol. 6, Iss. 7, pp. 2346-2360
Open Access | Times Cited: 10

Showing 10 citing articles:

Combination therapies and other therapeutic approaches targeting the NLRP3 inflammasome and neuroinflammatory pathways: a promising approach for traumatic brain injury
Zana Montazeri-Khosh, Ahmad Ebrahimpour, Mina Keshavarz, et al.
Immunopharmacology and Immunotoxicology (2025), pp. 1-17
Closed Access | Times Cited: 2
HTLV-1 persistence and the oncogenesis of adult T cell leukemia/lymphoma
Charles R. M. Bangham
Blood (2023)
Open Access | Times Cited: 17
Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets
Shenglan Liu, Wei Dai, Bei Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
HTLV‐1 persistent infection and ATLL oncogenesis
Xiaorui Zuo, Ruoning Zhou, Sikai Yang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 15
Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets
Francesca Marino‐Merlo, Sandro Grelli, Antonio Mastino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14807-14807
Open Access | Times Cited: 6
OGG1 as an Epigenetic Reader Affects NFκB: What This Means for Cancer
Spiros Vlahopoulos, Lang Pan, Lokman Varışlı, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 148-148
Open Access | Times Cited: 5
Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, et al.
International review of cell and molecular biology (2023), pp. 97-148
Closed Access | Times Cited: 4
Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions
Robert Stuver, Steven M. Horwitz, Zachary D. Epstein‐Peterson
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 8, pp. 948-964
Closed Access | Times Cited: 4
OGG1 as an Epigenetic Reader Affects NFκB: What This Means for Cancer
Spiros Angelou Vlahopoulos, Lang Pan, Lokman Varışlı, et al.
(2023)
Open Access | Times Cited: 4
BET inhibitors induce NF-κB and E2F downregulation in Hodgkin and Reed–Sternberg cells
Sara Monzón, Eva Díaz, Claudia Geraldine Rita, et al.
Experimental Cell Research (2023) Vol. 430, Iss. 2, pp. 113718-113718
Closed Access
Page 1

Scroll to top